Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advances in Neurobiology|August 29, 2024
Neurodevelopmental and Neuropsychiatric DisordersMarianela Evelyn Traetta, Adriano Maia Chaves Filho, Elizabeth Toyin Akinluyi, et al.
IBRO Neuroscience Reports|February 21, 2024
Black seed oil reverses chronic antibiotic-mediated depression and social behaviour deficits via modulation of hypothalamic mitochondrial-dependent markers and insulin expressionMujeeb Adekunle Adedokun, Linus Anderson Enye, Elizabeth Toyin Akinluyi, et al.
Brain Research Bulletin|August 31, 2023
Sex differences of microglia in the healthy brain from embryonic development to adulthood and across lifestyle influencesBianca Caroline Bobotis, Olivia Braniff, Makenna Gargus, et al.
Drug Metabolism and Personalized Therapy|December 9, 2021
Virgin coconut oil abrogates depression-associated cognitive deficits by modulating hippocampal antioxidant balance, GABAergic and glutamatergic receptors in miceEdem Ekpenyong Edem, Blessing Eghosa Ihaza, Adedamola Adediran Fafure, et al.
Drug Metabolism and Personalized Therapy|May 18, 2021
<i>Lactobacillus plantarum</i> mitigates sexual-reproductive deficits by modulating insulin receptor expression in the hypothalamic-pituitary-testicular axis of hyperinsulinemic miceEdem Ekpenyong Edem, Blessing Uyo Nathaniel, Kate Eberechukwu Nebo, et al.
Psychopharmacology|November 18, 2021
Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depressionEdem Ekpenyong Edem, Collins-Kevin Chukwudi Anyanwu, Kate Eberechukwu Nebo, et al.
Psychoneuroendocrinology|September 7, 2023
Prolonged ketamine therapy differentially rescues psychobehavioural deficits via modulation of nitro-oxidative stress and oxytocin receptors in the gut-brain-axis of chronically-stressed miceEdem Ekpenyong Edem, Oluwatomisn Adeyosola Oguntala, Daniel Akinwale Ikuelogbon, et al.
Behavioural Brain Research|May 20, 2023
Quercetin abrogates lipopolysaccharide-induced depressive-like symptoms by inhibiting neuroinflammation via microglial NLRP3/NFκB/iNOS signaling pathwayOlusegun Adebayo Adeoluwa, Juliet Nneda Olayinka, Gladys Onyinye Adeoluwa, et al.
Pageof 1